170 related articles for article (PubMed ID: 9726099)
1. Irinotecan in cervical cancer.
Kavanagh JJ; Verschraegen CF; Kudelka AP
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):94-8. PubMed ID: 9726099
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan for the treatment of cervical cancer.
Verschraegen CF
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):32-4. PubMed ID: 12109804
[TBL] [Abstract][Full Text] [Related]
3. [Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Terauchi F
Nihon Rinsho; 2004 Oct; 62 Suppl 10():175-8. PubMed ID: 15535228
[No Abstract] [Full Text] [Related]
4. Irinotecan and radiation in combined-modality therapy for solid tumors.
Choy H; MacRae R
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
[TBL] [Abstract][Full Text] [Related]
5. Role of topoisomerase I inhibitors in small-cell lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan in epithelial ovarian cancer.
Gershenson DM
Oncology (Williston Park); 2002 May; 16(5 Suppl 5):29-31. PubMed ID: 12109803
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan and cisplatin in upper gastrointestinal malignancies.
Enzinger PC; Ilson DH; Saltz LB; O'Reilly EM; Kelsen DP
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):110-3. PubMed ID: 9726102
[TBL] [Abstract][Full Text] [Related]
8. [Irinotecan hydrochloride (CPT-11)].
Furue H
Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan in cancers of the lung and cervix.
Sandler A; van Oosterom AT
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S13-7. PubMed ID: 10630363
[TBL] [Abstract][Full Text] [Related]
10. [Irinotecan (CPT-11) therapy for advanced gastric cancer].
Sakata Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():386-92. PubMed ID: 11424411
[No Abstract] [Full Text] [Related]
11. [Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials].
Couteau C; Yakendji K; Terret C; Goncalves E; Armand JP
Bull Cancer; 1996 Jan; 83(1):3-10. PubMed ID: 8672854
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of irinotecan in patients with colorectal cancer.
Rothenberg ML
Semin Oncol; 1998 Oct; 25(5 Suppl 11):39-46. PubMed ID: 9786315
[TBL] [Abstract][Full Text] [Related]
13. Irinotecan HCl, an anticancer topoisomerase I inhibitor, frequently induces ovarian failure in premenopausal and perimenopausal women.
Tanaka T; Utsunomiya T; Utsunomiya H; Umesaki N
Oncol Rep; 2008 May; 19(5):1123-33. PubMed ID: 18425367
[TBL] [Abstract][Full Text] [Related]
14. CPT-11: an original spectrum of clinical activity.
Rothenberg ML
Semin Oncol; 1996 Feb; 23(1 Suppl 3):21-6. PubMed ID: 8633249
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase-I inhibitors in gynecologic tumors.
Haluska P; Rubin E; Verschraegen CF
Hematol Oncol Clin North Am; 1999 Feb; 13(1):43-61, vii-viii. PubMed ID: 10080069
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and irinotecan in upper gastrointestinal malignancies.
O'Reilly EM; Ilson DH
Oncology (Williston Park); 2001 Mar; 15(3 Suppl 5):42-5. PubMed ID: 11301840
[TBL] [Abstract][Full Text] [Related]
17. Alternative dosing schedules for irinotecan.
Rothenberg ML; Kuhn JG; Schaaf LJ; Drengler RL; Eckhardt SG; Villalona-Calero MA; Hammond L; Miller LL; Petit RG; Rowinsky EK; Von Hoff DD
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):68-71. PubMed ID: 9726095
[TBL] [Abstract][Full Text] [Related]
18. CPT-11 (irinotecan) in the treatment of colorectal cancer.
Armand JP; Ducreux M; Mahjoubi M; Abigerges D; Bugat R; Chabot G; Herait P; de Forni M; Rougier P
Eur J Cancer; 1995; 31A(7-8):1283-7. PubMed ID: 7577037
[TBL] [Abstract][Full Text] [Related]
19. CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity.
Bleiberg H
Tumori; 1997; 83(1 Suppl):S85-6. PubMed ID: 9154078
[No Abstract] [Full Text] [Related]
20. UFT plus calcium folinate/irinotecan in colorectal cancer.
Twelves C
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):51-4. PubMed ID: 10442362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]